SHPK
protein-codingsedoheptulokinase
Gene summary
The protein encoded by this gene has weak homology to several carbohydrate kinases, a class of proteins involved in the phosphorylation of sugars as they enter a cell, inhibiting return across the cell membrane. Sequence variation between this novel gene and known carbohydrate kinases suggests the possibility of a different substrate, cofactor or changes in kinetic properties distinguishing it from other carbohydrate kinases. The gene resides in a region commonly deleted in cystinosis patients, suggesting a role as a modifier for the cystinosis phenotype. The genomic region is also rich in Alu repetitive sequences, frequently involved in chromosomal rearrangements. [provided by RefSeq, Jul 2008]
- CARKL
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014969
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0014969
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014969
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014969
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical
Intervention: General
Rationale: The clinical relevance is unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SHPK variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013276.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 65 | 4 | 69 | |||
| missense | 134 | 8 | 3 | 145 | ||
| nonsense | 5 | 5 | ||||
| start loss | 0 | |||||
| frameshift | 8 | 8 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 148 | 73 | 7 | 228 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_037408.2 | 7 | MANE Select | |
| Ensembl | ENSP00000225519.3 | 7 | MANE Select | |
| Ensembl | ENSP00000652966.1 | 6 | Standard | |
| Ensembl | ENSP00000753886.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pentose phosphate pathway (hexose monophosphate shunt)
- Metabolism of carbohydrates
- Metabolism
Biological Process
- carbohydrate metabolic process
- pentose-phosphate shunt
- pentose-phosphate shunt, non-oxidative branch
- phosphorylation
- cellular response to interleukin-13
Molecular Function
- ATP binding
- sedoheptulokinase activity
Cellular Component
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000225519
- Coding exons
- 7
- Length
- 28061
- Individuals with no LoFs
- 125495
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 251
- Defined
- 125747
- p
- 0.00100
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.166 | 303 | 295 | 1.03 | 0.0000178 | 3067 |
| Missense (PolyPhen) | 114 | 106.54 | 1.0701 | 1112 | ||
| Synonymous | -0.724 | 145 | 134 | 1.08 | 0.00000952 | 1034 |
| Loss of Function | 0.438 | 20 | 22.2 | 0.900 | 0.00000140 | 196 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00074 | 0.00074 | rare |
| Latino/Admixed American | 0.0012 | 0.0012 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.0014 | 0.0014 | notable |
| South Asian | 0.00098 | 0.00098 | rare |
| Other | 0.00098 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a modulator of macrophage activation through control of glucose metabolism. {ECO:0000250}.;
- Disease
- DISEASE: Sedoheptulokinase deficiency (SHPKD) [MIM:617213]: An autosomal recessive metabolic disease characterized by increased urinary erythritol and sedoheptulose. Neonatal cholestasis, hypoglycemia, anemia, congenital arthrogryposis multiplex, multiple contractures and dysmorphisms have been reported in SHPKD patients, but the relationship of these features to the SHPKD is unclear. {ECO:0000269|PubMed:25647543}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- RVIS EVS
- -0.4
- RVIS percentile EVS
- 26.93
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.977
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |